Navigation Links
Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results
Date:2/8/2013

t on Form 10-K for the year ended December 31, 2011 and Form 10-Q for the quarter ended September 30, 2012. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.

 NEUROCRINE BIOSCIENCES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) (unaudited) Three Months EndedDecember 31, Year EndedDecember 31, 2012201120122011Revenues:Sponsored research and development

$
3,959

$
,873

$
8,897

$
,462Milestones and license fees

7,988

9,237

34,243

66,951Total revenues

21,947

11,110

53,140

77,413Operating expenses:Research and development

9,097

8,002

37,163

30,951General and administrative

3,311

2,668

13,437

12,458Cease-use expense

957

(7)

1,092

82Total operating expenses

13,365

10,663

51,692

43,491Income from operations

8,582

447

1,448

33,922Other income:Gain on sale/disposal of assets

7

58

32

242Deferred gain on real estate

766

744

3,042

2,953Investment income, net

130

77

489

418Other income, net

5

5

14

36Total other income

908

884

3,577

3,649Net income

$
9,490

$
,331

$
5,025

$
37,571Net income per common share:Basic

$
.14

$
.02

$
.08

$
.68Diluted

$
.14

$
.02

$
.08

$
.67Shares used in the calculation of net income per common share:Basic

66,406

55,259

65,619

55,176Diluted

67,720

56,461

66
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
2. Neurocrine Biosciences Reports Third Quarter 2012 Results
3. Neurocrine Biosciences Reports Second Quarter 2012 Results
4. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
5. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
6. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
7. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast
8. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
11. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Toronto, Canada (PRWEB) May 21, 2013 ... there is a strong push within the industry ... Development and Manufacturing Organizations and pharma companies often ... time frames. , Microtablets, developed in collaboration with ... how effective outsourcing can bring products to market ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
(Date:5/21/2013)... Emerson Resources Inc. , a premier pharmaceutical ... Company’s Chief Executive Officer and Chairman of the Board, ... service. As part of Emerson Resources’ planned leadership succession ... as Dr. Signorino’s successor. , Dr. Signorino is ... a significant contribution to the field during his extensive ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... , PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: ... a voluntary recall of five lots and voluntary market withdrawal ... ® . Shire is taking this action because some Daytrana ... meet their release liner removal specification, and as a result, ...
... , , COLUMBIA, Md., Dec. 2 ... it intends to release the results of its fourth quarter and ... Eastern Time (ET). Following the release, at 4:45 p.m. ET ... investors. All interested parties may listen to the call live ...
... , NEW YORK, Dec. 2 Nearly 600 ... to explore novel development approaches and innovative funding strategies at ... FasterCures, the Washington-based center of the Milken Institute, ... needed to turn a scientific discovery into an accessible therapy. ...
Cached Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/18/2013)... (May 18, 2013) Research presented at Digestive ... digestive health through diet and lifestyle. , ... by reduced muscle strength, fatigue and poor quality ... patients are in remission. A randomized, double blind, ... vitamin D supplementation corresponded to significant relief of ...
(Date:5/17/2013)... South, but the night belongs to the amphibians. In ... humidity and the sounds of wildlife. , The Southeast, ... salamanders, is the center of amphibian biodiversity in our nation. ... their symphonic choruses, the scientists of the U.S. Geological Survey,s ... , Amphibians, which rely on water for part ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... Amlie Perez is preparing to tally the number of ... a row. The objective? To measure the impact of the ... the amphibian populations of southern Quebec. A graduate student ... visit more than 50 swamps and lakes. Last year she ...
... at The University of Western Ontario finds the sauces you ... unforeseen health benefits. The research, led by Western biology ... be more than just tasty sauces they can also ... co-authored by Mark Bernards and Christopher Guglielmo in Western,s department ...
... HOUSTON , March 23 Today, Texas ... the TMS320C5515 Fingerprint Development Kit, a complete signal chain solution ... fingerprint biometric features in reduced time to market.  This robust ... digital signal processor (DSP), two widely-used sensor types (swipe and ...
Cached Biology News:Counting frogs: Why monitoring our amphibian populations is important 2Spice up your health this barbecue season 2Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 2Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 3Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 4Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 5Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 6
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Proliferin (C-14)...
... of your ValveBank system! Program your ... Macintosh computer using graphic 'click-and-drag' timebars. Save ... out program listings, then download your programs ... step., EasyCode is used for programming before ...
Biology Products: